首页    期刊浏览 2024年11月08日 星期五
登录注册

文章基本信息

  • 标题:Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
  • 本地全文:下载
  • 作者:Jessica E. Sagers ; Adam S. Brown ; Sasa Vasilijic
  • 期刊名称:Scientific Reports
  • 电子版ISSN:2045-2322
  • 出版年度:2018
  • 卷号:8
  • 期号:1
  • 页码:5437
  • DOI:10.1038/s41598-018-23609-7
  • 语种:English
  • 出版社:Springer Nature
  • 摘要:The computational repositioning of existing drugs represents an appealing avenue for identifying effective compounds to treat diseases with no FDA-approved pharmacotherapies. Here we present the largest meta-analysis to date of differential gene expression in human vestibular schwannoma (VS), a debilitating intracranial tumor, and use these data to inform the first application of algorithm-based drug repositioning for this tumor class. We apply an open-source computational drug repositioning platform to gene expression data from 80 patient tumors and identify eight promising FDA-approved drugs with potential for repurposing in VS. Of these eight, mifepristone, a progesterone and glucocorticoid receptor antagonist, consistently and adversely affects the morphology, metabolic activity, and proliferation of primary human VS cells and HEI-193 human schwannoma cells. Mifepristone treatment reduces VS cell viability more significantly than cells derived from patient meningiomas, while healthy human Schwann cells remain unaffected. Our data recommend a Phase II clinical trial of mifepristone in VS.
国家哲学社会科学文献中心版权所有